Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat GDF11 ELISA Kit (AC2686)
Cat.#: ASET-1275
Specifications
Description Rat GDF11 ELISA Kit allows for the in vitro quantitative determination of rat GDF11 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1014 Human iNOS ELISA Kit (AC2425) Quantitative inquiry ASET-2280 Mouse Luteinizing Hormone ELISA Kit (AC3691) Quantitative inquiry ASET-1356 Mouse Malondialdehyde ELISA Kit (AC2767) Quantitative inquiry ASET-1945 Human ZnT1 ELISA Kit (AC3356) Quantitative inquiry ASET-2176 Human Bim ELISA Kit (AC3587) Quantitative inquiry ASET-2081 Human HMGN1 ELISA Kit (AC3492) Quantitative inquiry ASET-2032 Human Urocortin 3 ELISA Kit (AC3443) Quantitative inquiry ASET-1717 Mouse DLL4 ELISA Kit (AC3128) Quantitative inquiry ASET-1331 Rat Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC2742) Quantitative inquiry ASET-2263 Mouse PPAR gamma ELISA Kit (AC3674) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket